Dale Bearman, MD
Gynecology · Marietta, GANPI 1457348377
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,853 of the $2,099 with a category attached, or 88.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$387
- Astellas Pharma US Inc$325
- Pfizer$161
- Bayer$125
- Hologic Sales And Service, LLC$113
- Aspira Women's Health Inc$93
- plus $894 from 24 others
What the payments were for
- Food & beverage$1,85388%
- Education$24612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $387 |
| Astellas Pharma US Inc | 9 | $325 |
| Pfizer | 8 | $161 |
| Bayer | 8 | $125 |
| Hologic Sales And Service, LLC | 6 | $113 |
| Aspira Women's Health Inc | 1 | $93 |
| Coopersurgical, Inc. | 4 | $88 |
| Myovant Sciences Inc. | 4 | $84 |
| Exeltis, USA Inc. | 4 | $83 |
| Avion Pharmaceuticals | 6 | $76 |
| Millicent US Inc | 3 | $65 |
| Evofem Biosciences, Inc. | 3 | $59 |
| Therapeuticsmd, Inc. | 2 | $39 |
| Mayne Pharma Commercial LLC | 2 | $33 |
| Baxter Healthcare | 2 | $32 |
| Organon | 2 | $30 |
| Amgen | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Shield Therapeutics Inc | 1 | $26 |
| Roche Diagnostics Corporation | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$2,099 in reported general payments places this provider in the 70th percentile of 119 gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 42 | $1,901 |
| Escitalopram Oxalate | 11 | $180 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Marietta
- Wendy GilesMarietta$2K
- Soyini HawkinsPeachtree Corners$585K
- Rama RaoAtlanta$343K
- Michael RandellAtlanta$196K
- Ceana NezhatAtlanta$157K
- Sujatha ReddyAtlanta$116K
- Thomas LyonsConyers$71K
- Jennifer ElliottAlpharetta$55K
- Daniel EstevesLawrenceville$16K
- Nathan MordelRoswell$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.